Form 4 for LCTX Lineage Cell Therapeutics, Inc.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-22 · accession 0000950170-24-130592 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-22 | LCTX | Mulroy Michael H. | Dir | P - Purchase | $0.57 | +40.0K | 298.6K | +15% | +$22.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-11-22 | P | A | 40,000 | $0.57 | 298,555 | D | — | — |